Conference discussion: Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
作者信息
Wahba A, Vonk A, Bidstrup B
出版信息
Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):139-40.
PMID:21322159
Abstract
摘要
Zotero 插件